lnu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Patienters attityder och åsikter kring generisk substitution
Linnaeus University, Faculty of Health and Life Sciences, Department of Chemistry and Biomedical Sciences.
2016 (Swedish)Independent thesis Basic level (degree of Bachelor), 10 credits / 15 HE creditsStudent thesis
Abstract [en]

The Swedish drug expenses increased sharply during the 1990. The increase in cost of drug spending declined from year 2002, due to the introduction of generic substitution. ‘Generic substitution’ is a pharmaceutical term used to describe the substitution of a prescribed drug (that has an expired patent) with an equivalent alternative containing the same drug substance, formulation and strength. The substituted drug has similar bioavailability, and are approved as generics by “Läkemedelsverket” (compare EMA, FDA)

This substitution of drugs has led to an eight million Swedish kronor reduction in annual costs on government drug spending. Money that can be allocated to other sectors in the healthcare system.

Despite these huge savings, patients have been criticizing the generic exchange system due to perceived side effects, suspicion of a lower quality and uncertainty and confusion about what drugs to use. This might add up to poorer compliance, risk for double-medication and medicinal errors. Johan Wallér, CEO of Apoteksföreningen (a lobbying organization for pharmacy retailers), claims that an estimate of 200.000 people every year are making errors when medicating, and experience an inferior medical effect due to generic exchange.

The aim of this study was to identify the problems and opportunities experienced by patients due to the introduction of generic substitution. A questionnaire study was performed including 280 customers, presenting prescriptions on drugs available for drug substitution in five different pharmacies, in Malmo (town in the southern part of Sweden).

In the survey, questions were asked about what knowledge the customers had of generic substitution and from whom they had received this information. Questions were also asked about medical errors.

The results from the questionnaire show that 5/280 had experienced problem with generic substitution that had had impact on their well-being. Also, patients over 56 on a long-term medication, and with multiple interchangeable medicines often run into problems with generic exchange. The patients in the survey reported a shortage/lack of communication and information from the doctors about the pros and cons with generic drugs.

Some patients were confused about package looking different from what they were used to, different size, form and colour of tablets.  Approximately 46 % of the patients consider the shape of tablets to be important, and 23 % said the size. Changing the shape and size of tablets may therefore have negative consequences.

There is a risk of medication errors associated with the use of generics. In this survey, few people experienced side effect, but on a national basis this problem cannot be ignored, since millions of prescriptions are subject to generic substitution. This calls for the need of informing the customers in pharmacies and by physicians in a proper way.

Place, publisher, year, edition, pages
2016. , p. 49
Keywords [sv]
Generisk substitution
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:lnu:diva-59554OAI: oai:DiVA.org:lnu-59554DiVA, id: diva2:1060760
Subject / course
Pharmacy
Educational program
Bachelor of Science Programme in Pharmacy, 180 credits
Supervisors
Examiners
Available from: 2016-12-30 Created: 2016-12-29 Last updated: 2016-12-30Bibliographically approved

Open Access in DiVA

fulltext(2757 kB)76 downloads
File information
File name FULLTEXT01.pdfFile size 2757 kBChecksum SHA-512
39eb878c8f3ba433f8a00c568c7823daccc61f05401b3a6825821ee64afd18908c0ef13da8228027bd53c6b55603aa1c2cc336ff6156508575d3fd48ab305eca
Type fulltextMimetype application/pdf

Search in DiVA

By author/editor
Sahebezai, Benazir
By organisation
Department of Chemistry and Biomedical Sciences
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 76 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
Total: 153 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf